About us
Applied research in regeneration
BioRegenis develops pharmaceutical and health products, bringing together scientific research and industrial development.
BioRegenis was founded in Italy around a precise idea: helping the body rebuild its own tissue, rather than simply compensating for its loss.
It is not a goal reached through insight alone. It takes time, method and patient capital, and it is measured in clinical phases completed rather than in announcements. That is why we built the company around two programmes pursued thoroughly, rather than around a broad portfolio to display.
01
How we work
Each product advances through defined, verifiable phases following pharmaceutical development protocols.
Each product advances through defined, verifiable phases following pharmaceutical development protocols. No phase is skipped, and none is declared complete before it has answered the question it exists to answer.
We work with external research facilities for activities requiring specific expertise or instrumentation, while keeping scientific direction of the programmes in house.
For work requiring specialist instrumentation or expertise we draw on external research facilities, selected according to the requirements of the phase under way.
Why we publish our progress
Silence can mean everything or nothing.
In this field, communication tends to concentrate on positive results. The rhythm of announcements therefore becomes a poor indicator of what is actually happening.
We have chosen to make the position of every programme public across the development phases, updated by our team. This is not a gesture of openness: it is the simplest way to be judged on something verifiable.
It also means publishing when a programme has stalled, or is advancing more slowly than expected. That seems an acceptable cost.
The expertise
Developing a pharmaceutical product requires two crafts that rarely coincide: research, which forms and tests hypotheses, and industrial development, which turns them into something manufacturable and compliant.
BioRegenis is built to hold the two together.
The group brings together research and industrial development expertise, with scientific direction of the programmes kept in house.
- 2
- Programmes in development
- 5
- Phases tracked
- 75%
- Average progress
- Italy
- Based in
The team
Team details will be published shortly.